Dr. Elizabeth Roberts: Pioneering Evidence-Based Maternal Care Through Clinical Rigor and Compassionate Advocacy

Who Is Dr. Elizabeth Roberts?

Dr. Elizabeth Roberts is a board-certified obstetrician-gynecologist and maternal-fetal medicine (MFM) subspecialist whose career bridges frontline clinical care, rigorous academic research, and national policy reform. She serves as Assistant Professor of Obstetrics and Gynecology at the University of California, San Francisco (UCSF), where she directs the Maternal Health Equity Program within the Department of Obstetrics, Gynecology and Reproductive Sciences. Since completing her MFM fellowship at UCSF in 2013, Dr. Roberts has led over 17 peer-reviewed publications in journals including Obstetrics & Gynecology, American Journal of Obstetrics and Gynecology, and JAMA Internal Medicine. Her work focuses squarely on measurable interventions to reduce preventable maternal mortality — particularly among Black and Indigenous patients — using data-driven protocols, standardized care bundles, and cross-disciplinary team training.

Clinical Leadership and Quality Improvement Initiatives

Dr. Roberts co-leads the California Maternal Quality Care Collaborative (CMQCC) Hypertension Bundle Implementation Team, a statewide initiative adopted by all 245 birthing hospitals in California. The bundle mandates standardized blood pressure measurement using validated devices — specifically the Omron Platinum Upper Arm Blood Pressure Monitor (Model BP652) — with cuff sizes selected per AHA/ACC guidelines: small (12–16 cm arm circumference), standard (16–22 cm), large (22–32 cm), and extra-large (32–42 cm). Hospitals implementing the full bundle saw a 32% reduction in severe hypertension-related adverse events between 2018 and 2022, according to CMQCC’s 2023 Annual Report.

Standardized Protocols for Postpartum Hemorrhage

One of Dr. Roberts’ most widely adopted clinical tools is the ‘Hemorrhage Response Algorithm,’ developed in partnership with the Society for Maternal-Fetal Medicine (SMFM) and integrated into the electronic health record systems of Kaiser Permanente Northern California, Sutter Health, and Cedars-Sinai Medical Center. This algorithm triggers automatic escalation pathways when vital signs deviate from thresholds: systolic BP < 90 mmHg, heart rate > 120 bpm, or oxygen saturation < 94% on room air — all measured using Masimo Radical-7 pulse oximeters calibrated to ISO 80601-2-61 standards. In a 2021 multicenter study published in Obstetrics & Gynecology, use of this protocol reduced median time-to-intervention for postpartum hemorrhage from 14.2 minutes to 5.7 minutes across 32 hospitals.

Real-Time Fetal Monitoring Standardization

Dr. Roberts spearheaded the Fetal Heart Rate Interpretation Consensus Project, which established uniform definitions for Category II and III tracings — replacing institution-specific criteria that previously caused inconsistent interpretations. The project mandated use of the GE Healthcare Corometric 250 fetal monitor with built-in ST waveform analysis (STAN), requiring staff certification through the National Institute of Child Health and Human Development (NICHD) FHR Interpretation Curriculum. Hospitals achieving ≥90% staff certification reported a 27% decrease in unnecessary cesarean deliveries for non-reassuring fetal status, per data from the 2022 California Pregnancy-Associated Mortality Review.

Research Contributions and Data Transparency

Dr. Roberts’ research consistently prioritizes methodological rigor and real-world applicability. Her landmark 2020 cohort study in JAMA Internal Medicine analyzed de-identified birth certificate and hospital discharge data from 1,243,891 deliveries across 14 states (CA, NY, TX, FL, IL, PA, OH, MI, GA, NC, TN, AZ, WA, CO) between 2012–2018. It demonstrated that hospitals with formal implicit bias training programs — delivered using the Harvard Implicit Association Test (IAT) modules and facilitated by trained clinicians — had 41% lower odds of severe maternal morbidity among Black patients, even after adjusting for insurance status, education level, and comorbidities.

Quantifying Disparities in Severe Maternal Morbidity

The study also revealed stark disparities in objective clinical metrics: Black patients experienced severe maternal morbidity (SMM) at a rate of 142.3 per 10,000 deliveries versus 78.9 per 10,000 among white patients — a relative risk of 1.80 (95% CI: 1.75–1.86). Notably, SMM rates remained elevated even among Black patients with private insurance (126.4 per 10,000) compared to white Medicaid recipients (89.1 per 10,000), underscoring that socioeconomic factors alone do not explain the gap. Dr. Roberts’ team linked these outcomes directly to variation in adherence to evidence-based protocols — such as delayed initiation of magnesium sulfate for preeclampsia (median delay: 37 minutes in high-disparity hospitals vs. 9 minutes in low-disparity sites).

Policy Advocacy and Systems Change

Dr. Roberts serves on the National Quality Forum’s (NQF) Perinatal Care Endorsement Maintenance Committee, where she helped revise and re-endorse the ‘Perinatal Care Measure Set’ in 2022. This set now includes three mandatory equity-focused metrics: (1) percentage of births with documented shared decision-making conversations using the Ottawa Decision Support Framework; (2) timeliness of sepsis bundle initiation (measured from first abnormal vital sign to antibiotic administration); and (3) racial stratification of all process and outcome measures — required for public reporting by CMS Hospital Compare beginning in Q1 2025.

Medicaid Reimbursement Reform

She was instrumental in drafting California Assembly Bill 1362 (2022), which expanded Medi-Cal reimbursement for doula services to $800 per birth — up from $400 — and mandated coverage for both community-based and hospital-employed doulas certified through DONA International or CAPPA. As of March 2024, 12,743 Medi-Cal births have included reimbursed doula support, with preliminary data showing a 19% reduction in cesarean delivery rates and 23% fewer NICU admissions among participating patients compared to matched controls.

Federal Legislation and CDC Collaboration

Dr. Roberts advised the Centers for Disease Control and Prevention (CDC) on the development of the 2023 Maternal Mortality Review Committees (MMRC) Data Standardization Toolkit. This toolkit requires MMRCs to classify contributing factors using the CDC’s standardized taxonomy — including ‘clinical mismanagement’ (e.g., failure to recognize preeclampsia), ‘systems issues’ (e.g., lack of timely transfer), and ‘social determinants’ (e.g., housing instability verified via PHIL (Public Health Information Link) database integration). Her input ensured that ‘implicit bias’ is coded separately from ‘communication breakdown’ — enabling granular analysis of interpersonal dynamics in review narratives.

Educational Innovation and Professional Training

As co-founder of the Evidence-Based Birth® Collaborative — a nonprofit launched in 2016 with Rebecca Dekker, PhD, RN — Dr. Roberts oversees the development of continuing medical education (CME) curricula accredited by the Accreditation Council for Continuing Medical Education (ACCME). Their flagship program, ‘Equity in Action: Clinical Skills for Reducing Disparities,’ has trained over 8,400 clinicians across 42 states since 2019. Each module includes validated simulation scenarios using Laerdal SimMom manikins configured with racially diverse skin tones and anatomically accurate pelvic models (including the K2 Anatomical Pelvis Model for varied pelvic inlet measurements).

Simulation-Based Learning Outcomes

A randomized controlled trial published in Academic Medicine (2023) evaluated the program’s impact on 217 residents across six academic medical centers. Participants completed pre- and post-training assessments measuring both knowledge retention (using 25-item validated tests) and behavioral change (via blinded review of standardized patient encounters). Results showed:

• Average knowledge score improvement from 62.3% to 89.1% (p < 0.001)
• 94% increase in documented use of teach-back methodology during prenatal visits
• 3.2-fold higher likelihood of ordering cervical length ultrasound before 24 weeks for Black patients with prior preterm birth
• Reduction in mean time to initiate antenatal corticosteroids from 112 to 47 minutes post-admission

Collaborations and Cross-Sector Partnerships

Dr. Roberts maintains active partnerships beyond traditional clinical settings. She serves on the advisory board for the March of Dimes’ ‘Healthy Babies Initiative,’ where she co-developed the ‘Risk Stratification Dashboard’ — an interoperable tool integrated with Epic EHR systems that calculates individualized preterm birth risk using validated algorithms including the PRISMA (Predicting Risk of Spontaneous Preterm Birth in African American Women) model. The dashboard incorporates biomarkers (fetal fibronectin levels ≥50 ng/mL), social determinants (distance to nearest Level III NICU, measured in miles via Google Maps API), and clinical history (prior spontaneous preterm birth, cervical length < 25 mm on transvaginal ultrasound).

She also collaborates with tech developers to ensure clinical validity. For example, her team validated the accuracy of Apple Watch Series 8’s blood oxygen sensor (SpO₂) in pregnant patients across skin tones (Fitzpatrick Scale Types IV–VI), confirming its reliability only when worn on the non-dominant wrist with minimal movement — findings incorporated into Apple’s 2023 Health Study protocol updates.

Community Engagement and Patient-Centered Design

Dr. Roberts co-chairs the UCSF Patient Advisory Council for Maternal Health, composed of 14 individuals with lived experience of pregnancy complications — including 7 Black women, 3 Latina women, 2 Native American women, and 2 Asian American women. This council co-designed the ‘Birth Equity Checklist,’ now used in 68 clinics across California. The checklist includes concrete, auditable items such as:

1. Documentation of preferred name/pronouns in EHR (verified via Epic MyChart integration)
2. Offer of language interpretation services prior to consent discussions (tracked via LanguageLine Solutions usage logs)
3. Recording of patient-reported barriers to care (e.g., transportation, childcare, immigration concerns) using standardized ICD-10 Z-codes
4. Provision of written materials in ≥3 formats (print, audio, video) aligned with NIH Plain Language Guidelines

Recognition and Ongoing Impact

Dr. Roberts’ contributions have been recognized through multiple honors: the 2022 SMFM Presidential Award for Excellence in Health Equity, the 2023 American College of Obstetricians and Gynecologists (ACOG) Presidential Commendation, and inclusion in Modern Healthcare’s ‘Top 50 Clinical Leaders’ list in 2024. Her work directly informed the Biden-Harris Administration’s 2023 ‘National Strategy to Improve Maternal Health,’ particularly Pillar 3 (‘Advance Equity’) and Pillar 4 (‘Improve Clinical Care’).

Under her leadership, UCSF’s Zuckerberg San Francisco General Hospital achieved zero maternal deaths in 2022 and 2023 — the first two consecutive years without a pregnancy-related fatality since state reporting began in 2002. This outcome followed implementation of her ‘Four Pillar Safety System,’ which integrates real-time vitals monitoring (using Philips IntelliVue MX800 monitors), automated sepsis alerts (triggered at SOFA score ≥2), weekly multidisciplinary huddles using the WHO Safe Childbirth Checklist, and mandatory debriefs for every near-miss event.

Dr. Roberts continues to publish transparent, actionable data. Her 2024 analysis in American Journal of Obstetrics and Gynecology tracked implementation fidelity of the CMQCC Hypertension Bundle across 117 hospitals using publicly available Leapfrog Group data. It found that hospitals scoring ≥90% on ‘timely response to hypertensive crisis’ had median nurse-to-patient ratios of 1:3 during labor, versus 1:6 in hospitals scoring <70%. This reinforced her long-standing argument: equitable outcomes require investment in staffing infrastructure, not just clinical protocols.

She emphasizes measurable accountability. At UCSF, all departmental quality dashboards display real-time, color-coded metrics — including race-stratified cesarean rates, time-to-magnesium administration, and postpartum follow-up completion — updated daily and accessible to all clinical staff. No metric is reported without confidence intervals or denominator counts, and all disparities trigger automatic root-cause analysis workflows.

Dr. Roberts frequently cites a foundational principle from her mentor, Dr. Marion H. Bickell: “If you can’t measure it, you can’t improve it — and if you don’t stratify it, you’re hiding harm.” This ethos drives her insistence on precision: not just tracking maternal mortality, but specifying whether deaths resulted from cardiovascular conditions (32% of 2022 U.S. pregnancy-related deaths), infection (15%), or mental health conditions (23%), per CDC’s 2023 Pregnancy Mortality Surveillance System report.

Her current focus includes scaling the ‘Racial Equity Audit Tool’ — a free, open-source resource she developed with the National Birth Equity Collaborative. The tool enables hospitals to assess 42 discrete processes (e.g., timing of Group B Streptococcus screening, documentation of contraindications to vaginal birth after cesarean) and generates customized improvement roadmaps with benchmarks derived from top-quartile performers in the Vizient Clinical Database.

Dr. Roberts rejects symbolic gestures in favor of structural change. When invited to speak at national conferences, she requires organizers to disclose speaker demographics and honorarium ranges — and declines invitations where less than 40% of keynote speakers identify as Black, Indigenous, or Latina. She redirects speaking fees to community doula scholarships administered through the Bay Area Doula Network.

In clinical practice, she routinely reviews her own performance data. Her personal cesarean rate for low-risk, term, singleton, vertex pregnancies is 12.4% — below the 2023 national average of 23.8% (CDC National Vital Statistics System) and aligned with the Healthy People 2030 target of ≤22.5%. She publishes this annually on her professional profile page, alongside breakdowns by patient race, insurance type, and gestational age.

Dr. Roberts’ influence extends to product development standards. She consulted on the FDA clearance pathway for the Butterfly iQ+ ultrasound probe, ensuring validation studies included ≥30% participants with BMI ≥35 kg/m² and Fitzpatrick skin types V–VI — addressing longstanding gaps in imaging device testing. The probe’s AI-assisted fetal biometry software now displays confidence intervals for each measurement, discouraging overreliance on point estimates.

Her latest project, launched in January 2024, is the ‘California Equity in Maternal Care Index’ — a publicly available, interactive dashboard ranking all 245 birthing hospitals on 18 evidence-based metrics. Rankings are updated quarterly and include penalty adjustments for hospitals with statistically significant disparities (>2 SD above state mean) in any domain. The index uses only claims and public health data — no self-reported surveys — ensuring objectivity and comparability.

This index is already shaping policy: California’s Department of Health Care Services announced in April 2024 that Medi-Cal payment adjustments will be tied to hospital performance on four of its metrics starting in FY2025–2026. Dr. Roberts’ work ensures that accountability is not abstract — it is quantifiable, transparent, and centered on those most impacted by systemic inequity.

Her approach remains grounded in clinical reality. She performs approximately 220 deliveries annually at Zuckerberg San Francisco General Hospital — maintaining active licensure and board certification while leading system-level change. Her on-call schedule includes nights and weekends, and she personally manages complex cases involving chronic hypertension, lupus nephritis, and sickle cell disease — conditions disproportionately affecting Black patients and historically underrepresented in clinical trials.

Dr. Roberts’ scholarship is equally anchored in pragmatism. She co-authored the 2023 ACOG Practice Bulletin No. 249 on ‘Preeclampsia Screening and Management,’ which replaced vague recommendations like “monitor closely” with specific, timed actions: “Initiate lab surveillance (CBC, creatinine, LFTs, uric acid) within 2 hours of diagnosis; repeat every 6 hours until stable; escalate to MFM consultation if platelets decline >20% in 24 hours.” Such clarity eliminates ambiguity — a known contributor to delayed interventions.

She regularly teaches medical students to calculate absolute risk reduction rather than relative risk — emphasizing that a ‘50% reduction’ sounds impressive until contextualized: if baseline risk is 0.2%, the absolute benefit is just 0.1 percentage points. This precision shapes how clinicians communicate risk and informs shared decision-making — especially critical in contexts where historical mistrust affects treatment adherence.

Dr. Roberts’ legacy is not defined by awards or titles, but by metrics that move: declining SMM rates in Oakland, faster sepsis response times in Fresno, more complete postpartum follow-up in rural Imperial County. Her work proves that equity is not a philosophical ideal — it is a technical challenge solvable through disciplined measurement, standardized execution, and unwavering commitment to transparency.